Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 1924-1928

  Tousoulis, Dimitris ^a   Siasos, Gerasimos ^a   Maniatis, Konstantinos ^a   Oikonomou, Evangelos ^a   Kioufis, Stamatios ^a   Zaromitidou, Marina ^a   Paraskevopoulos, Thodoris ^a   Michalea, Stavroula ^a   Kollia, Christina ^a   Miliou, Antigoni ^a   Kokkou, Eleni ^a   Papavassiliou, Athanasios G ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Arterial stiffness; Atherosclerosis; Coronary artery disease; Osteopontin; Osteoprotogerin; Vascular calcification

Indexed keywords

OSTEOPONTIN; OSTEOPROTEGERIN;

ADULT; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PULSE WAVE;

ARTERIAL STIFFNESS; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; OSTEOPONTIN; OSTEOPROTOGERIN; VASCULAR CALCIFICATION;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPONTIN; OSTEOPROTEGERIN; SEVERITY OF ILLNESS INDEX; VASCULAR STIFFNESS;

EID: 84883302865     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.001     Document Type: Article

References (35)

1. J.L. Cavalcante, J.A. Lima, A. Redheuil, and M.H. Al-Mallah Aortic stiffness: current understanding and future directions J Am Coll Cardiol 57 2011 1511 1522
2. C.C. Chen, K.C. Hung, I.C. Hsieh, and M.S. Wen Association between peripheral vascular disease indexes and the numbers of vessels obstructed in patients with coronary artery disease Am J Med Sci 343 2012 52 55
3. T. Weber, J. Auer, and M.F. O'Rourke Arterial stiffness, wave reflections, and the risk of coronary artery disease Circulation 109 2004 184 189
4. E. Stepien, E. Wypasek, K. Stopyra, M. Konieczynska, M. Przybylo, and M. Pasowicz Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals Clin Biochem 44 2011 826 831
5. D. Tousoulis, G. Siasos, and K. Maniatis Novel biomarkers assessing the calcium deposition in coronary artery disease Curr Med Chem 19 2012 901 920
6. L. Wexler, B. Brundage, and J. Crouse Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group Circulation 94 1996 1175 1192
7. S. Ashkar, G.F. Weber, and V. Panoutsakopoulou Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity Science 287 2000 860 864
8. K. Isoda, K. Nishikawa, and Y. Kamezawa Osteopontin plays an important role in the development of medial thickening and neointimal formation Circ Res 91 2002 77 82
9. V. Ophascharoensuk, C.M. Giachelli, and K. Gordon Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis Kidney Int 56 1999 571 580
10. M. Scatena, L. Liaw, and C.M. Giachelli Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease Arterioscler Thromb Vasc Biol 27 2007 2302 2309
11. H.J. Cho, and H.S. Kim Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification Curr Atheroscler Rep 11 2009 206 213
12. L.C. Hofbauer, S. Khosla, C.R. Dunstan, D.L. Lacey, W.J. Boyle, and B.L. Riggs The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption J Bone Miner Res 15 2000 2 12
13. T.J. Yun, P.M. Chaudhary, and G.L. Shu OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40 J Immunol 161 1998 6113 6121
14. L.C. Hofbauer, C. Shui, and B.L. Riggs Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells Biochem Biophys Res Commun 280 2001 334 339
15. M. Schoppet, A.M. Sattler, J.R. Schaefer, M. Herzum, B. Maisch, and L.C. Hofbauer Increased osteoprotegerin serum levels in men with coronary artery disease J Clin Endocrinol Metab 88 2003 1024 1028
16. R. Ohmori, Y. Momiyama, and H. Taniguchi Plasma osteopontin levels are associated with the presence and extent of coronary artery disease Atherosclerosis 170 2003 333 337
17. S. Jono, Y. Ikari, and A. Shioi Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease Circulation 106 2002 1192 1194
18. C. Vlachopoulos, I. Dima, and K. Aznaouridis Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals Circulation 112 2005 2193 2200
19. R. Asmar, A. Benetos, and J. Topouchian Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies Hypertension 26 1995 485 490
20. G. Siasos, D. Tousoulis, and C. Vlachopoulos The impact of oral l-arginine supplementation on acute smoking-induced endothelial injury and arterial performance Am J Hypertens 22 2009 586 592
21. G.G. Gensini A more meaningful scoring system for determining the severity of coronary heart disease Am J Cardiol 51 1983 606
22. J.A. Berliner, M. Navab, and A.M. Fogelman Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics Circulation 91 1995 2488 2496
23. A.M. Sattler, M. Schoppet, J.R. Schaefer, and L.C. Hofbauer Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease Calcif Tissue Int 74 2004 103 106
24. G. Siasos, D. Tousoulis, Z. Siasou, C. Stefanadis, and A.G. Papavassiliou Shear stress, protein kinases and atherosclerosis Curr Med Chem 14 2007 1567 1572
25. C.R. Dhore, J.P. Cleutjens, and E. Lutgens Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques Arterioscler Thromb Vasc Biol 21 2001 1998 2003
26. H.M. Koo, H.M. Do, and E.J. Kim Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients Atherosclerosis 219 2011 925 930
27. A. Vik, E.B. Mathiesen, and J. Brox Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromso Study J Thromb Haemost 9 2011 638 644
28. E.R. O'Brien, M.R. Garvin, and D.K. Stewart Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques Arterioscler Thromb 14 1994 1648 1656
29. S. Hirota, M. Imakita, and K. Kohri Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification Am J Pathol 143 1993 1003 1008
30. Y. Momiyama, R. Ohmori, and Z.A. Fayad Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis Atherosclerosis 210 2010 668 670
31. G. Siasos, D. Tousoulis, C. Antoniades, E. Stefanadi, and C. Stefanadis l-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis? Int J Cardiol 116 2007 300 308
32. E.L. Schiffrin Vascular stiffening and arterial compliance. Implications for systolic blood pressure Am J Hypertens 17 2004 39S 48S
33. S.M. Kim, J. Lee, and O.H. Ryu Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity Clin Endocrinol (Oxf) 63 2005 594 598
34. M. Zagura, M. Serg, and P. Kampus Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects Am J Hypertens 23 2010 586 591
35. L. Bazzichi, L. Ghiadoni, and A. Rossi Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis Mol Med 15 2009 402 406